TPG has made an NBIO to acquire InvoCare at A$12.65/share for an equity value of A$1.8bn. TPG has also bought up 17.8% of the company. We'd buy here at a 5.2% spread to the offer price.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.